Skip to main content
. 2022 Jul 26;10:915943. doi: 10.3389/fped.2022.915943

Table 5B.

The distribution of vitamin D provision for patients with JIA depending on the form of the disease.

Characteristics 25(OH)D ** P
Me [Q1; Q3] * P <20 ng/mL n (%) 21–29 ng/mL n (%) >30 ng/mL, n (%)
1 2 3
Oligoarticular,
n = 67
25,8
[19,4; 37,6]
- 21
(31,3%)
17
(25,4%)
29
(43,3%)
-
Polyarticular RF-negative,
n = 49
21,7
[15,8; 31,6]
0,14 20
(40,8%)
14
(28,6%)
15
(30,6%)
p1 = 0,292
p2 = 0,701
p3 = 0,165
Polyarticular RF-positive,
n = 3
2
(66,7%)
1
(33,3%)
- p1 = 0,203
p2 = 0,758
Systemic,
n = 18
21,3
[15,4; 30,3]
0,24 8
(44,4%)
5
(27,8%)
5
(27,8%)
p1 = 0,298
p2 = 0,837
p3 = 0,234
Enthesitis-related arthritis,
n = 11
20,2
[9,5; 22,0]
0,06 5
(45,5%)
4
(36,4%)
2
(18,2%)
p1 = 0,358
p2 = 0, 447
p3 = 0,115
Psoriatic,
n = 1
19,8 - 1 (100%) - - -
Undifferentiated,
n =1
21,9 - - 1 (100%) - -
*

Level of significant differences between vitamin D provision for the oligoarticular JIA group compared with other forms of JIA using the Mann-Whitney test.

**

Level of significant differences between vitamin D provision for the oligoarticular JIA group compared with other forms of JIA using the Pearson criterion (χ2).

JIA, juvenile idiopathic arthritis.